Anil K. Mishra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anil K. Mishra has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Anjani Kumar Tiwari
Department of Chemistry, Babasaheb Bhimrao Ambedkar University (A Central University), Lucknow, India
8 shared publications Deepa Sinha
Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, Brig. S. K. Mazumdar Road, Delhi‐110054, India
4 shared publicationsGauri Shukla
Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, Delhi, India
4 shared publicationsDipti Kakkar
Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, Brig. S. K. Mazumdar Road, Delhi‐110054, India
3 shared publicationsHarish Chandra
Department of Chemistry, University of Delhi, Delhi, India
3 shared publicationsKrishna Chuttani
Institute of Nuclear Medicine and Allied Sciences
3 shared publications
Latest Publications
- 1 June 2011
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 26 (3) , 389-393
Correlation of Physical Parameters During Radiochemical Synthesis of 18 F Positron Emission Tomography Radiopharmaceuticals
Positron emission tomography is a highly specialized imaging technique using short-lived radiolabel substances to produce extremely high resolution images of the body's biological function. The 18F− ion is produced via the 18O(p,n)18F reaction using a silver target cell filled with 1.4 mL of enriched [18O] water. On a typical run, the target is irradiated for 45 minutes with 16.5 MeV protons (on target) and an average beam current of 5–45 mA. When the same reaction takes place with [16O] water [13N] Ammonia is produced as the primary product by the abstraction of hydrogen from water. This study investigated the physical parameters of medical cyclotron during the radiochemical process with induced radioactivity flux and mutual correlation of physical parameters for 16.5 MeV medical cyclotron at the INMAS Delhi, India. It is observed that by getting farther from the target, the relative number of low-energy neutrons increases while the overall flux of neutrons decreases. This is due to multiple scattering of high-energy neutrons in the walls and eventually absorption of low-energy neutrons. The other parameters are also linked with each other which are correlatable.
- 1 June 2011
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 26 (3) , 389-393
Correlation of Physical Parameters During Radiochemical Synthesis of 18 F Positron Emission Tomography Radiopharmaceuticals
Positron emission tomography is a highly specialized imaging technique using short-lived radiolabel substances to produce extremely high resolution images of the body's biological function. The 18F− ion is produced via the 18O(p,n)18F reaction using a silver target cell filled with 1.4 mL of enriched [18O] water. On a typical run, the target is irradiated for 45 minutes with 16.5 MeV protons (on target) and an average beam current of 5–45 mA. When the same reaction takes place with [16O] water [13N] Ammonia is produced as the primary product by the abstraction of hydrogen from water. This study investigated the physical parameters of medical cyclotron during the radiochemical process with induced radioactivity flux and mutual correlation of physical parameters for 16.5 MeV medical cyclotron at the INMAS Delhi, India. It is observed that by getting farther from the target, the relative number of low-energy neutrons increases while the overall flux of neutrons decreases. This is due to multiple scattering of high-energy neutrons in the walls and eventually absorption of low-energy neutrons. The other parameters are also linked with each other which are correlatable.
- Retracted
- 25 March 2011
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 77 (5) , 388-392
Retracted: Kinetics of Formation for Lanthanide (III) Complexes of DTPA‐(Me‐Trp)2 used as Imaging Agent
Diethlenetriamine‐N,N,N′N′′N′′‐pentaacetic acid (DTPA)‐bis (amide) analogs have been synthesized and evaluated as a potential biomedical imaging agents. Imaging and biodistribution studies were performed in mice that showed a significant accumulation of DTPA analogs in brain. The stability and protonation constants of the complexes formed between the ligand [DTPA‐(Me‐Trp)2] and Gd3+, Eu3+, and Cu2+ have been determined by pH potentiometry (Gd3+, Eu3+) and spectrophotometry (Cu2+) at 25 °C and at constant ionic strength maintained by 0.10 m KCl. The kinetic inertness of Gd [DTPA‐(Me‐Trp)2] was characterized by the rates of exchange reactions with Zn2+ and Eu3+. In the Eu3+ exchange, a second‐order [H+] dependence was found for the pseudo‐first‐order rate constant [k0 = (4.5 ± 1.2) × 10−6/s; k1 = 0.58 ± 0.1 /m/s, k2 = (6.6 ± 0.2) × 104 /m2/s, k3 = (4.8 ± 0.8) × 10−4/m/s]. In the Eu3+ exchange, at pH <5.0, the rate decreases with increasing concentration of the exchanging ion. At physiological pH, the kinetic inertness of [DTPA‐(Me‐Trp)2] is more inert than GdDTPA2−, the most commonly used MRI contrast agent (t1/2 = 127 h). High kinetic stability is an important requirement for the Gd complexes used as contrast enhancement agents in magnetic resonance imaging.
- 25 March 2011
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 77 (5) , 388-392
RetractedRetracted: Kinetics of Formation for Lanthanide (III) Complexes of DTPA‐(Me‐Trp)2 used as Imaging Agent
Diethlenetriamine‐N,N,N′N′′N′′‐pentaacetic acid (DTPA)‐bis (amide) analogs have been synthesized and evaluated as a potential biomedical imaging agents. Imaging and biodistribution studies were performed in mice that showed a significant accumulation of DTPA analogs in brain. The stability and protonation constants of the complexes formed between the ligand [DTPA‐(Me‐Trp)2] and Gd3+, Eu3+, and Cu2+ have been determined by pH potentiometry (Gd3+, Eu3+) and spectrophotometry (Cu2+) at 25 °C and at constant ionic strength maintained by 0.10 m KCl. The kinetic inertness of Gd [DTPA‐(Me‐Trp)2] was characterized by the rates of exchange reactions with Zn2+ and Eu3+. In the Eu3+ exchange, a second‐order [H+] dependence was found for the pseudo‐first‐order rate constant [k0 = (4.5 ± 1.2) × 10−6/s; k1 = 0.58 ± 0.1 /m/s, k2 = (6.6 ± 0.2) × 104 /m2/s, k3 = (4.8 ± 0.8) × 10−4/m/s]. In the Eu3+ exchange, at pH <5.0, the rate decreases with increasing concentration of the exchanging ion. At physiological pH, the kinetic inertness of [DTPA‐(Me‐Trp)2] is more inert than GdDTPA2−, the most commonly used MRI contrast agent (t1/2 = 127 h). High kinetic stability is an important requirement for the Gd complexes used as contrast enhancement agents in magnetic resonance imaging.
- 1 December 2010
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 25 (6) , 645-655
Comparative Evaluation of Glutamate-Sensitive Radiopharmaceuticals: Technetium-99m–Glutamic Acid and Technetium-99m–Diethylenetriaminepentaacetic Acid–bis(Glutamate) Conjugate for Tumor Imaging
Single-photon emission computed tomography has become a significant imaging modality with huge potential to visualize and provide information of anatomic dysfunctions that are predictive of future diseases. This imaging tool is complimented by radiopharmaceuticals/radiosubstrates that help in imaging specific physiological aspects of the human body. The present study was undertaken to explore the utility of technetium-99m ( 99m Tc)–labeled glutamate conjugates for tumor scintigraphy. As part of our efforts to further utilize the application of chelating agents, glutamic acid was conjugated with a multidentate ligand, diethylenetriaminepentaacetic acid (DTPA). The DTPA–glutamate conjugate [DTPA-bis(Glu)] was well characterized by IR, NMR, and mass spectroscopy. The biological activity of glutamic acid was compared with its DTPA conjugate by radiocomplexation with 99m Tc (labeling efficiency ≥98%). In vivo studies of both the radiolabeled complexes 99m Tc-Glu and 99m Tc-DTPA-bis(Glu) were then carried out, followed by gamma scintigraphy in New Zealand albino rabbits. Improved serum stability of 99m Tc-labeled DTPA conjugate indicated that 99m Tc remained bound to the conjugate up to 24 hours. Blood clearance showed a relatively slow washout of the DTPA conjugate when compared with the labeled glutamate. Biodistribution characteristics of the conjugate in Balb/c mice revealed that DTPA conjugation of glutamic acid favors less accumulation in the liver and bone and rapid renal clearance. Tumor scintigraphy in mice showed increasing tumor accumulation, stable up to 4 hours. These preliminary studies show that 99m Tc-DTPA-bis(Glu) can be a useful radiopharmaceutical for diagnostic applications in single-photon emission computed tomography imaging.
- 1 December 2010
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 25 (6) , 645-655
Comparative Evaluation of Glutamate-Sensitive Radiopharmaceuticals: Technetium-99m–Glutamic Acid and Technetium-99m–Diethylenetriaminepentaacetic Acid–bis(Glutamate) Conjugate for Tumor Imaging
Single-photon emission computed tomography has become a significant imaging modality with huge potential to visualize and provide information of anatomic dysfunctions that are predictive of future diseases. This imaging tool is complimented by radiopharmaceuticals/radiosubstrates that help in imaging specific physiological aspects of the human body. The present study was undertaken to explore the utility of technetium-99m ( 99m Tc)–labeled glutamate conjugates for tumor scintigraphy. As part of our efforts to further utilize the application of chelating agents, glutamic acid was conjugated with a multidentate ligand, diethylenetriaminepentaacetic acid (DTPA). The DTPA–glutamate conjugate [DTPA-bis(Glu)] was well characterized by IR, NMR, and mass spectroscopy. The biological activity of glutamic acid was compared with its DTPA conjugate by radiocomplexation with 99m Tc (labeling efficiency ≥98%). In vivo studies of both the radiolabeled complexes 99m Tc-Glu and 99m Tc-DTPA-bis(Glu) were then carried out, followed by gamma scintigraphy in New Zealand albino rabbits. Improved serum stability of 99m Tc-labeled DTPA conjugate indicated that 99m Tc remained bound to the conjugate up to 24 hours. Blood clearance showed a relatively slow washout of the DTPA conjugate when compared with the labeled glutamate. Biodistribution characteristics of the conjugate in Balb/c mice revealed that DTPA conjugation of glutamic acid favors less accumulation in the liver and bone and rapid renal clearance. Tumor scintigraphy in mice showed increasing tumor accumulation, stable up to 4 hours. These preliminary studies show that 99m Tc-DTPA-bis(Glu) can be a useful radiopharmaceutical for diagnostic applications in single-photon emission computed tomography imaging.
- 1 October 2010
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 25 (5) , 559-562
Quantitative Structure–Activity Relationship Analysis of 4(3H)-Quinazolone Derivatives as Tyrosine Kinase Inhibitors by Multiple Linear Regression
Computational chemistry is playing an increasingly important role in drug design and discovery, structural biology, and quantitative structure–activity relationship studies. A series of 4(3H)-quinozolone derivatives were screened for two-dimensional quantitative structure–activity relationship studies and subsequently their absorption, distribution, metabolism, and excretion (ADME) properties with the use of soft modeling techniques after selecting suitable descriptors for molecular structure. Multiple linear regression analysis was performed for this study. The final quantitative structure–property relationship mathematical models were found as follows: Equation \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland,xspace}\usepackage{amsmath,amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6} \begin{document}$$[Y = \log (1/{\rm MIC})] \ \Xi \ {\rm pMIC} =$$ \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland,xspace}\usepackage{amsmath,amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6} \begin{document}$$0.2165 \kappa (1) - 2.082 \chi (3) - 0.3235\mu_{\rm T} - 0.2185 \mu_x - 100.6q_{\rm N} - 35.42$$ \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland,xspace}\usepackage{amsmath,amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6} \begin{document}$$0.2185 \kappa (1) - 2.1575 \chi (3) - 0.3622 \mu_{\rm T} - 0.2142 \mu_x - 100.4q_{\rm N} - 31.25$$ \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland,xspace}\usepackage{amsmath,amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6} \begin{document}$$0.0015 \omega - 2.0822 \chi (3) - 0.1252 \mu_{\rm T} - 0.2180 \mu_x - 112.9q_{\rm N} - 36.05$$ \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland,xspace}\usepackage{amsmath,amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6} \begin{document}$$- 2.108 \chi (3) - 0.0035E_{\rm T} - 0.2033 \mu_x - 3.489q_{\rm esp} - 92.60q_{\rm N} - 33.20$$ \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland,xspace}\usepackage{amsmath,amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6} \begin{document}$$0.2140 \kappa (1) - 2.186 \chi (3) - 0.0036O_{xxx} - 0.0016O_{xyy} - 78.02q_{\rm N} - 31.52$$ \end{document}- 1 October 2010
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 25 (5) , 559-562
Quantitative Structure–Activity Relationship Analysis of 4(3H)-Quinazolone Derivatives as Tyrosine Kinase Inhibitors by Multiple Linear Regression
Computational chemistry is playing an increasingly important role in drug design and discovery, structural biology, and quantitative structure–activity relationship studies. A series of 4(3H)-quinozolone derivatives were screened for two-dimensional quantitative structure–activity relationship studies and subsequently their absorption, distribution, metabolism, and excretion (ADME) properties with the use of soft modeling techniques after selecting suitable descriptors for molecular structure. Multiple linear regression analysis was performed for this study. The final quantitative structure–property relationship mathematical models were found as follows: Equation \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland,xspace}\usepackage{amsmath,amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6} \begin{document}$$[Y = \log (1/{\rm MIC})] \ \Xi \ {\rm pMIC} =$$ \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland,xspace}\usepackage{amsmath,amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6} \begin{document}$$0.2165 \kappa (1) - 2.082 \chi (3) - 0.3235\mu_{\rm T} - 0.2185 \mu_x - 100.6q_{\rm N} - 35.42$$ \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland,xspace}\usepackage{amsmath,amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6} \begin{document}$$0.2185 \kappa (1) - 2.1575 \chi (3) - 0.3622 \mu_{\rm T} - 0.2142 \mu_x - 100.4q_{\rm N} - 31.25$$ \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland,xspace}\usepackage{amsmath,amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6} \begin{document}$$0.0015 \omega - 2.0822 \chi (3) - 0.1252 \mu_{\rm T} - 0.2180 \mu_x - 112.9q_{\rm N} - 36.05$$ \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland,xspace}\usepackage{amsmath,amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6} \begin{document}$$- 2.108 \chi (3) - 0.0035E_{\rm T} - 0.2033 \mu_x - 3.489q_{\rm esp} - 92.60q_{\rm N} - 33.20$$ \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland,xspace}\usepackage{amsmath,amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6} \begin{document}$$0.2140 \kappa (1) - 2.186 \chi (3) - 0.0036O_{xxx} - 0.0016O_{xyy} - 78.02q_{\rm N} - 31.52$$ \end{document}- 1 October 2010
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 25 (5) , 571-575
Design, Synthesis, and Fluorescence Lifetime Study of Benzothiazole Derivatives for Imaging of Amyloids
The imaging of the distribution of β-amyloid plaques in the brain is becoming an important diagnostic modality in Alzheimer's disease. The present study reports the synthesis of novel benzothiazole derivatives. The final products were characterized by spectral techniques such as FTIR, 1 H NMR, and electrospray ionization–mass spectrometry. The structure–activity relationship of these benzothiazole derivatives is also reported. The K i values of these derivatives were evaluated by competitive binding assay studies. The analogs were labeled with 99m Tc for the potential diagnostic imaging of Alzheimer's disease using stannous chloride as a reducing agent. The radiochemical stability was found to be ≥ 90% for both the compounds and they were stable for 10–12 hours in human serum. Biodistribution studies of the 99m Tc complex in normal mice were performed after intravenous injection through the tail vein. The data showed high initial brain uptakes at 2 minutes (2.2% ± 0.1% ID/g), and brain activities washed out to 0.3% ± 0.02% ID/g at 6 hours. In conclusion, benzothiazole derivatives showed excellent binding affinities for β-amyloid aggregates and high initial brain uptakes in normal mice.
- 1 October 2010
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 25 (5) , 571-575
Design, Synthesis, and Fluorescence Lifetime Study of Benzothiazole Derivatives for Imaging of Amyloids
The imaging of the distribution of β-amyloid plaques in the brain is becoming an important diagnostic modality in Alzheimer's disease. The present study reports the synthesis of novel benzothiazole derivatives. The final products were characterized by spectral techniques such as FTIR, 1 H NMR, and electrospray ionization–mass spectrometry. The structure–activity relationship of these benzothiazole derivatives is also reported. The K i values of these derivatives were evaluated by competitive binding assay studies. The analogs were labeled with 99m Tc for the potential diagnostic imaging of Alzheimer's disease using stannous chloride as a reducing agent. The radiochemical stability was found to be ≥ 90% for both the compounds and they were stable for 10–12 hours in human serum. Biodistribution studies of the 99m Tc complex in normal mice were performed after intravenous injection through the tail vein. The data showed high initial brain uptakes at 2 minutes (2.2% ± 0.1% ID/g), and brain activities washed out to 0.3% ± 0.02% ID/g at 6 hours. In conclusion, benzothiazole derivatives showed excellent binding affinities for β-amyloid aggregates and high initial brain uptakes in normal mice.
- 1 February 2010
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 25 (1) , 117-121
SAR of Cu (II) Thiosemicarbazone Complexes as Hypoxic Imaging Agents: MM3 Analysis and Prediction of Biologic Properties
Copper(II) bis(thiosemicarbazone) are very useful for blood flow and hypoxic imaging. The aim of this study was to identify structure-activity relationships (SARs) within a series of analogues with different substitution patterns in the ligands, in order to design improved hypoxia imaging agents and elucidate hypoxia selectivity mechanisms. Genetic algorithms (GAs) were used to develop specific copper metal-ligand force field parameters for the MM3 force-field calculations. These new parameters produced results in good agreement with experiment and previously reported copper metal-ligand parameters. A successful quantitative SAR (QSAR) for predicting the several classes of Cu(II)-chelating ligands was built using a training set of 21 Cu(II) complexes. The QSAR exhibited a correlation between the predicted and experimental test set. The QSAR preformed with great accuracy; r2 = 0.95 and q2 = 0.90 utilizing a leave-one-out cross-validation with multiple linear regression analysis to find correlation between different calculated molecular descriptors of these complexes. The final QSAR mathematical models were found as the following: The resulting models could act as an efficient strategy for estimating the hypoxic conditions through imaging and provide some insights into the structural features related to the biological activity of these compounds.
- 1 February 2010
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 25 (1) , 117-121
SAR of Cu (II) Thiosemicarbazone Complexes as Hypoxic Imaging Agents: MM3 Analysis and Prediction of Biologic Properties
Copper(II) bis(thiosemicarbazone) are very useful for blood flow and hypoxic imaging. The aim of this study was to identify structure-activity relationships (SARs) within a series of analogues with different substitution patterns in the ligands, in order to design improved hypoxia imaging agents and elucidate hypoxia selectivity mechanisms. Genetic algorithms (GAs) were used to develop specific copper metal-ligand force field parameters for the MM3 force-field calculations. These new parameters produced results in good agreement with experiment and previously reported copper metal-ligand parameters. A successful quantitative SAR (QSAR) for predicting the several classes of Cu(II)-chelating ligands was built using a training set of 21 Cu(II) complexes. The QSAR exhibited a correlation between the predicted and experimental test set. The QSAR preformed with great accuracy; r2 = 0.95 and q2 = 0.90 utilizing a leave-one-out cross-validation with multiple linear regression analysis to find correlation between different calculated molecular descriptors of these complexes. The final QSAR mathematical models were found as the following: The resulting models could act as an efficient strategy for estimating the hypoxic conditions through imaging and provide some insights into the structural features related to the biological activity of these compounds.
- 1 October 2009
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 24 (5) , 615-620
Synthesis and Biological Evaluation of 99m Tc-DTPA-bis(His) as a Potential Probe for Tumor Imaging with SPECT
99mTc-DTPA-bis(His) conjugate has been synthesized and evaluated as a potential radiopharmaceutical for tumor imaging. The compound was synthesized by the covalent coupling of DTPA bis(anhydride) with L-histidine and was characterized on the basis of infrared, nuclear magnetic resonance, and mass spectroscopy. 99mTc-labeled compound was found stable for about 24 hour under physiologic conditions with a more than 96% radiolabeling yield. A blood kinetic study of this complex showed a biexponential pattern as well as quick washout from the blood circulation. The biologic t1/2(F) and t1/2(S) was found to be 45 ± 0.041 minutes and 6.5 hours ± 0.039 minutes, respectively. Imaging and biodistribution studies were performed in mice bearing Ehrlich ascites tumor (EAT) tumors in the right thigh. The EAT tumors in the mice were readily visible in the γ-images and showed major accumulation of the radiotracer in the kidney. Biodistribution studies revealed a high accumulation at the tumor site. Tumor-to-muscle ratios were 5.07 ± 0.08 and 4.2 ± 0.01 at 1 and 4 hours, respectively. The receptor binding of the 99mTc-DTPA-bis(His) by an established human tumor cell line (U87-MG) showed KD = 1.08 nM. The preliminary studies of the 99mTc-DTPA-bis(His) are encouraging to carrying out further in vivo experiments for targeted tumor imaging.
- 1 October 2009
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 24 (5) , 615-620
Synthesis and Biological Evaluation of 99m Tc-DTPA-bis(His) as a Potential Probe for Tumor Imaging with SPECT
99mTc-DTPA-bis(His) conjugate has been synthesized and evaluated as a potential radiopharmaceutical for tumor imaging. The compound was synthesized by the covalent coupling of DTPA bis(anhydride) with L-histidine and was characterized on the basis of infrared, nuclear magnetic resonance, and mass spectroscopy. 99mTc-labeled compound was found stable for about 24 hour under physiologic conditions with a more than 96% radiolabeling yield. A blood kinetic study of this complex showed a biexponential pattern as well as quick washout from the blood circulation. The biologic t1/2(F) and t1/2(S) was found to be 45 ± 0.041 minutes and 6.5 hours ± 0.039 minutes, respectively. Imaging and biodistribution studies were performed in mice bearing Ehrlich ascites tumor (EAT) tumors in the right thigh. The EAT tumors in the mice were readily visible in the γ-images and showed major accumulation of the radiotracer in the kidney. Biodistribution studies revealed a high accumulation at the tumor site. Tumor-to-muscle ratios were 5.07 ± 0.08 and 4.2 ± 0.01 at 1 and 4 hours, respectively. The receptor binding of the 99mTc-DTPA-bis(His) by an established human tumor cell line (U87-MG) showed KD = 1.08 nM. The preliminary studies of the 99mTc-DTPA-bis(His) are encouraging to carrying out further in vivo experiments for targeted tumor imaging.
- 8 July 2009
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 74 (2) , 159-164
99mTc‐DTPA‐Amino Acids Conjugate as Specific SPECT Pharmaceuticals for Tumor Imaging
99mTc‐Diethylene triamine pentaacetic acid‐bis (amide) conjugates have been synthesized and evaluated as a potential radiopharmaceutical for tumor imaging. The compounds were synthesized by the condensation reaction of DTPA bis(anhydride) with different l‐amino acids (methyl tryptophan, and 5‐hydroxy tryptophan) and were characterized on the basis of IR, NMR, and Mass spectroscopy. 99mTc‐labeled compounds were found stable for about 24 h under physiological conditions with more than 95% radiolabeling yield. Blood kinetic studies of all these complexes showed a bi‐exponential pattern as well as quick wash out from the blood circulation. The biological t1/2(F) and t1/2(S) were found to be 20 ± 0.001 min for DTPA‐(Me‐Trp)2 and 18 ± 0.001 min for DTPA‐(5HT)2 and t1/2 (slow) 5 h 45 min ± 0.001, 5 h 30 ± 0.001 min for DTPA‐(Me‐Trp)2, and DTPA‐(5HT)2, respectively. Imaging and biodistribution studies were performed in mice bearing Ehrlich ascites tumor (EAT) tumors in right thigh. Radioconjugate derived from l‐5‐hydroxytryptophan exhibited remarkable localization at tumor site; whereas radiotracer derived from l‐methyl tryptophan shows relatively less accumulation at the tumor site. Tumor‐to‐muscles ratios were 5.07 ± 0.001, and 4.2 ± 0.001 at 1 and 4 h for 99mTc‐DTPA‐(Me trp)2 and 4.97 ± 0.001 and 5.8 ± 0.001 at 1 and 4 h after postinjection for 99mTc‐DTPA‐(5HT)2, respectively. The preliminary results with these amino acid based ligands are encouraging to carrying out further in vivo experiments for targeted tumor imaging.
- 8 July 2009
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 74 (2) , 159-164
99mTc‐DTPA‐Amino Acids Conjugate as Specific SPECT Pharmaceuticals for Tumor Imaging
99mTc‐Diethylene triamine pentaacetic acid‐bis (amide) conjugates have been synthesized and evaluated as a potential radiopharmaceutical for tumor imaging. The compounds were synthesized by the condensation reaction of DTPA bis(anhydride) with different l‐amino acids (methyl tryptophan, and 5‐hydroxy tryptophan) and were characterized on the basis of IR, NMR, and Mass spectroscopy. 99mTc‐labeled compounds were found stable for about 24 h under physiological conditions with more than 95% radiolabeling yield. Blood kinetic studies of all these complexes showed a bi‐exponential pattern as well as quick wash out from the blood circulation. The biological t1/2(F) and t1/2(S) were found to be 20 ± 0.001 min for DTPA‐(Me‐Trp)2 and 18 ± 0.001 min for DTPA‐(5HT)2 and t1/2 (slow) 5 h 45 min ± 0.001, 5 h 30 ± 0.001 min for DTPA‐(Me‐Trp)2, and DTPA‐(5HT)2, respectively. Imaging and biodistribution studies were performed in mice bearing Ehrlich ascites tumor (EAT) tumors in right thigh. Radioconjugate derived from l‐5‐hydroxytryptophan exhibited remarkable localization at tumor site; whereas radiotracer derived from l‐methyl tryptophan shows relatively less accumulation at the tumor site. Tumor‐to‐muscles ratios were 5.07 ± 0.001, and 4.2 ± 0.001 at 1 and 4 h for 99mTc‐DTPA‐(Me trp)2 and 4.97 ± 0.001 and 5.8 ± 0.001 at 1 and 4 h after postinjection for 99mTc‐DTPA‐(5HT)2, respectively. The preliminary results with these amino acid based ligands are encouraging to carrying out further in vivo experiments for targeted tumor imaging.
- 11 June 2009
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 74 (1) , 87-91
Quantitative Structure–Property Relationship (Correlation Analysis) of Phosphonic Acid‐Based Chelates in Design of MRI Contrast Agent
Nuclear magnetic resonance imaging is a very useful tool in modern medical diagnostics, especially when gadolinium (III)‐based contrast agents are administered to the patient with the aim of increasing the image contrast between normal and diseased tissues. With the use of soft modelling techniques such as quantitative structure–activity relationship/quantitative structure–property relationship after a suitable description of their molecular structure, we have studied a series of phosphonic acid for designing new MRI contrast agent. Quantitative structure–property relationship studies with multiple linear regression analysis were applied to find correlation between different calculated molecular descriptors of the phosphonic acid‐based chelating agent and their stability constants. The final quantitative structure–property relationship mathematical models were found as – quantitative structure–property relationship Model for phosphonic acid series (Model 1) − log KML = {5.00243(±0.7102)}− MR {0.0263(±0.540)}n = 12 l r l = 0.942 s = 0.183 F = 99.165 quantitative structure–property relationship Model for phosphonic acid series (Model 2) − log KML = {5.06280(±0.3418)}− MR {0.0252(± .198)}n = 12 l r l = 0.956 s = 0.186 F = 99.256.
- 11 June 2009
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 74 (1) , 87-91
Quantitative Structure–Property Relationship (Correlation Analysis) of Phosphonic Acid‐Based Chelates in Design of MRI Contrast Agent
Nuclear magnetic resonance imaging is a very useful tool in modern medical diagnostics, especially when gadolinium (III)‐based contrast agents are administered to the patient with the aim of increasing the image contrast between normal and diseased tissues. With the use of soft modelling techniques such as quantitative structure–activity relationship/quantitative structure–property relationship after a suitable description of their molecular structure, we have studied a series of phosphonic acid for designing new MRI contrast agent. Quantitative structure–property relationship studies with multiple linear regression analysis were applied to find correlation between different calculated molecular descriptors of the phosphonic acid‐based chelating agent and their stability constants. The final quantitative structure–property relationship mathematical models were found as – quantitative structure–property relationship Model for phosphonic acid series (Model 1) − log KML = {5.00243(±0.7102)}− MR {0.0263(±0.540)}n = 12 l r l = 0.942 s = 0.183 F = 99.165 quantitative structure–property relationship Model for phosphonic acid series (Model 2) − log KML = {5.06280(±0.3418)}− MR {0.0252(± .198)}n = 12 l r l = 0.956 s = 0.186 F = 99.256.